Autopsy report · NCT05541887
Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health
Cause of deathFunding or business
“Funding for this study was discontinued by the sponsor after the first year.”
Life of this trial
- Registered 1 year before it started.
- Suspended: paused, and may or may not restart.
- 25 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- University of Florida
- Sponsor type
- University, hospital or other
- Conditions
- Cognitive Performance; Memory; Mood; Anxiety
- Interventions
- Muscadine Wine Polyphenol; Placebo
- Participants
- 25 (planned, not actual)
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)
“Funding for this study has been discontinued.” - KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
“Study discontinued due to sponsor decision.” - The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study
“Study discontinued due to lack of study funding.” - Dim Light at Night in Patients With Obstructive Sleep Apnea
“The study was stopped due to lack of funding.” - Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
“The study was discontinued early due to lack of funding and slow enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.